Propeller

Propeller Health eyes Asia market with new expansion into Japan
By Laura Lovett | 01:04 pm | August 26, 2020
The new expansion is linked to a partnership the digital health company has with Novartis. 
Chris Hogg leaves Propeller; Wellsheet taps Dr. Fredrick Lindberg as VP of product management and other digital health hires and departures
By Laura Lovett | 03:54 pm | July 08, 2020
Also: Tyto Care names Colleen Sellers VP of marketing and MedSign adds John Kastanis to its senior advisory board. 
Anthem BCBS Ohio rolls out Propeller Health's sensors, Desert Oasis Healthcare to adopt Proteus' adherence tech, and more digital health deals
By Dave Muoio | 01:16 pm | August 21, 2018
Anthem Blue Cross and Blue Shield in Ohio has partnered with Propeller Health to provide sensor-equipped inhaler attachments to plan members with COPD.
Propeller Health announces $20M funding round, strategic partnership with Aptar Pharma
By Dave Muoio | 05:03 pm | May 30, 2018
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma.
Health Affairs study details results of digital inhaler partnership between Propeller, City of Louisville, non-profit
By Dave Muoio | 02:09 pm | April 03, 2018
A partnership between Louisville, Kentucky city leaders, a non-profit, and digital respiratory health company Propeller Health has led to clear improvements in local asthmatic residents’ inhaler use and symptoms, according to a study recently published in Health Affairs.
Pager hires new CEO and nine more digital health employee changes
By Heather Mack | 04:11 pm | January 05, 2017
New York City-based Pager, which offers an app for on-demand house call services, has appointed Walter Jin as the company’s new CEO.
Propeller gets FDA clearances to improve adherence to inhalers from Boehringer, GSK
By Jonah Comstock | 10:45 am | July 22, 2015
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim.